About 8 results found for searched term "PD-L1-IN-3" (0.091 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M22489 | Recombinant Human PD-L1 Protein (HEK293, C-His) | Cytokines and Growth Factors |
| Programmed cell death 1 ligand 1 | ||
| Programmed cell death 1 ligand 1 (PD-L1) is also known as cluster of differentiation (CD274) or B7 homolog 1 (B7-H1), is a member of the growing B7 family of immune molecules and is involved in the regulation of cellular and humoral immune responses. | ||
| M28729 | PD-1/PD-L1-IN 3 | PD-1/PD-L1 |
| PD-1/PD-L1-IN 3, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions. PD-1/PD-L1-IN 3 interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 can be used for the research of various diseases, including cancer and infectious diseases. | ||
| M31044 | PD-1/PD-L1-IN 3 TFA | PD-1/PD-L1 |
| PD-1/PD-L1-IN 3 TFA, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions. PD-1/PD-L1-IN 3 TFA interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. | ||
| M31307 | MAX-10181 | PD-1/PD-L1 |
| PD-1/PD-L1-IN-30 | ||
| MAX-10181 (PD-1/PD-L1-IN-30) is a PD-1/PD-L1 binding inhibitor with an IC50 value of 0.018 μM.It can be used in studies related to solid tumors. | ||
| M42029 | PD-L1-IN-3 | PD-1/PD-L1 |
| PD-L1-IN-3 is a compound that targets PD-1/PD-L1, the IC50 value and EC50 value is 4.97nM and 2.70 μM for inhibit PD-L1 and Jurkat T cells, respectively. | ||
| M42030 | PD-1/PD-L1-IN-32 | PD-1/PD-L1 |
| PD-1/PD-L1-IN-32 is a potent PD-1/PD-L1 inhibitor (IC50=2.4 nM), with anticancer activity. | ||
| M42033 | PD-1/PD-L1-IN-31 | PD-1/PD-L1 |
| PD-1/PD-L1-IN-31 is a PD-1/PD-L1 inhibitor (IC50=2.2 nM). | ||
| M42034 | PD-1/PD-L1-IN-33 | PD-1/PD-L1 |
| PD-1/PD-L1-IN-33 is a PD-1/PD-L1 inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
